Anti-retroviral therapy adherence in India (2012-18): A systematic review and meta-analysis.

IF 0.6 Q4 INFECTIOUS DISEASES Indian Journal of Sexually Transmitted Diseases and AIDS Pub Date : 2024-01-01 Epub Date: 2024-03-07 DOI:10.4103/ijstd.IJSTD_28_20
Saurav Basu, Yamini Marimuthu, Suneela Garg, Velusamy Saravanakumar, Balasubramanian Ganesh
{"title":"Anti-retroviral therapy adherence in India (2012-18): A systematic review and meta-analysis.","authors":"Saurav Basu, Yamini Marimuthu, Suneela Garg, Velusamy Saravanakumar, Balasubramanian Ganesh","doi":"10.4103/ijstd.IJSTD_28_20","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>India has 2.1 million people living with HIV/AIDS (PLHIV). The objective of this study was to ascertain the extent of anti-retroviral therapy (ART) adherence and reasons for nonadherence among PLHIV in India.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis using the following criteria: (1) Observational or experimental studies conducted in India and (2) English language studies. Published during January 2012-June 2018 with data collection during the same period (3). 95% ART adherence rate (primary outcome). We reviewed bibliographic databases (PubMed, Scopus) and extracted relevant data. The forest plot was used to display the meta-analysis results. Analyses were performed in Stata 14 using the \"Metaprop_one\" function.</p><p><strong>Results: </strong>A total of 511 records were identified after removing duplicates, 59 full-texts were screened of which 15 studies were included in the meta-analysis. Only one study was conducted in rural India, with <95% adherence reported by all its participants. The PLHIV reported several reasons for their ART nonadherence including forgetfulness (8/15), running out of pills (3/15), distance from the health center and associated travel (2/15), alcohol abuse (3/15), concealment of HIV status from family (2/15, felt stigma (2/15), depressive symptoms (2/15), and fear of side-effects (2/15). The overall pooled estimate of ART adherence was 54.1% (95% confidence interval [CI] 27%-81%), while among facility-based studies, the ≥95% adherence rate was significant higher. 62% (95% CI 46%-0.78%).</p><p><strong>Conclusions: </strong>Despite the universal provision of free of cost ART to all PLHIV in government health facilities in India, suboptimal adherence to treatment persists in nearly half of these patients.</p>","PeriodicalId":44880,"journal":{"name":"Indian Journal of Sexually Transmitted Diseases and AIDS","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11233045/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Sexually Transmitted Diseases and AIDS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijstd.IJSTD_28_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/7 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: India has 2.1 million people living with HIV/AIDS (PLHIV). The objective of this study was to ascertain the extent of anti-retroviral therapy (ART) adherence and reasons for nonadherence among PLHIV in India.

Methods: We conducted a systematic review and meta-analysis using the following criteria: (1) Observational or experimental studies conducted in India and (2) English language studies. Published during January 2012-June 2018 with data collection during the same period (3). 95% ART adherence rate (primary outcome). We reviewed bibliographic databases (PubMed, Scopus) and extracted relevant data. The forest plot was used to display the meta-analysis results. Analyses were performed in Stata 14 using the "Metaprop_one" function.

Results: A total of 511 records were identified after removing duplicates, 59 full-texts were screened of which 15 studies were included in the meta-analysis. Only one study was conducted in rural India, with <95% adherence reported by all its participants. The PLHIV reported several reasons for their ART nonadherence including forgetfulness (8/15), running out of pills (3/15), distance from the health center and associated travel (2/15), alcohol abuse (3/15), concealment of HIV status from family (2/15, felt stigma (2/15), depressive symptoms (2/15), and fear of side-effects (2/15). The overall pooled estimate of ART adherence was 54.1% (95% confidence interval [CI] 27%-81%), while among facility-based studies, the ≥95% adherence rate was significant higher. 62% (95% CI 46%-0.78%).

Conclusions: Despite the universal provision of free of cost ART to all PLHIV in government health facilities in India, suboptimal adherence to treatment persists in nearly half of these patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度坚持抗逆转录病毒疗法的情况(2012-18 年):系统回顾与荟萃分析。
背景:印度有 210 万艾滋病毒/艾滋病感染者(PLHIV)。本研究旨在确定印度艾滋病感染者坚持抗逆转录病毒疗法(ART)的程度以及不坚持的原因:我们采用以下标准进行了系统回顾和荟萃分析:(1) 在印度进行的观察性或实验性研究;(2) 英语研究。发表时间为 2012 年 1 月至 2018 年 6 月,数据收集时间为同期(3)。95%的抗逆转录病毒疗法坚持率(主要结果)。我们查阅了文献数据库(PubMed、Scopus)并提取了相关数据。森林图用于显示荟萃分析结果。分析在 Stata 14 中使用 "Metaprop_one "函数进行:除去重复的记录后,共找到 511 条记录,筛选出 59 篇全文,其中 15 项研究被纳入荟萃分析。只有一项研究是在印度农村地区进行的,结论是:尽管印度政府医疗机构向所有艾滋病毒携带者普遍提供免费抗逆转录病毒疗法,但近一半患者的治疗依从性仍不理想。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.60
自引率
25.00%
发文量
34
期刊最新文献
"Purple-Xed" by a baffling bleed - A clinical care conundrum. A case report of donovanosis in HIV-positive female. A case report of genital Crohn's disease with a brief review of Indian cases reported. A classic presentation of trichomoniasis in a patient of bacterial vaginosis. A cross-sectional study of noninfectious - nonvenereal genital dermatoses among adult males at tertiary care hospital in South Gujarat.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1